NPF-Funded Research

Identifying Metabolomic Markers of Disease Activity in Psoriatic Arthritis

Headshot to be 275 x 275 px

Principal Investigator: Vinod Chandran, D.M., Ph.D.
Institution:
University Health Network


Grant Mechanism: Translational Research Grant
Funding Amount: $199,510
Project Start Date: August 1, 2024
Project End Date: July 31, 2026
Status: Active
Keywords: Psoriatic Arthritis, Biomarkers, Multi-omics

Project Summary:

It is important to accurately determine whether PsA patients are in low, moderate, or high disease activity so that treatment is appropriately tailored. However, current methods of assessing disease activity are imprecise. Our purpose is to confirm whether small molecules (metabolites) that we have previously identified reliably measure PsA disease activity. We aim to comprehensively analyze three datasets to identify high-priority metabolites and develop blood tests to quantify these metabolites. We will then confirm if these metabolites are able to accurately measure PsA disease activity over time. A test based on these metabolites will better measure PsA disease activity, leading to better outcomes for patients.

How will your project help improve the lives of the 125 million affected by psoriatic disease?

Why is psoriatic disease research important to you, personally? What role will this award play in your research efforts or career development?






Researcher Profile:

Impact of NPF-Funded Research

The NPF has awarded over $30 million in research funding in recent years, with immeasurable impact on our community.

Read more

We Need Your Help

With your gift we can fund even more research to get better treatment and diagnostic options and someday, a cure.

Help fund critical research

NPF-Funded Research

Discover our other active research projects.

Learn more

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2024 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.